EURAZEO (EPA:RF) - EURAZEO CAPITAL ENTERS INTO EXCLUSIVE DISCUSSIONS WITH MONTAGU TO ACQUIRE DORC
Directive transparence : information réglementée Opérations de l'émetteur (acquisitions, cessions...)
13/03/2019 08:30
Cliquez ici pour télécharger le pdf
PRESS RELEASE
EURAZEO CAPITAL ENTERS INTO EXCLUSIVE DISCUSSIONS WITH MONTAGU TO ACQUIRE DORC
Paris, March 13, 2019 - Eurazeo Capital entered into exclusive discussions with
funds managed by Montagu Private Equity to acquire DORC (Dutch Ophthalmic
Research Center). Eurazeo Capital will invest close to 300MEUR in this
transaction. DORC will be the fifth investment of Eurazeo Capital IV. This
investment perfectly fits the strategy presented during the 2018 Annual Results
presentation.
Established in 1983 and headquartered in the Netherlands, the company operates
in the medical technology sector and is one of the global leading specialists
of vitreoretinal surgery. DORC designs, manufactures and distributes ophthalmic
surgery equipment, consumables and instruments.
The company serves over 5,700 surgeons and is recognized for its strong
innovation capability. DORC is a global company with a presence across 80
countries and enjoys strong market shares in Europe. DORC has more than 500
employees worldwide.
Additional financial information will be disclosed at the closing of the
transaction.
Marc Frappier, Managing Partner, Head of Eurazeo Capital commented: "The
acquisition of DORC fits perfectly with our investment strategy to support
growing businesses with a strong international development potential as they
scale up. Widely recognized as innovative and best in class by surgeons across
the world, the Company delivers remarkable financial performance. We expect to
leverage our international network to accelerate DORC's growth."
DORC will engage to immediately inform and consult the employee representative
bodies of the company. The final closing of the transaction will occur once the
process with employee representative bodies is finalized and clearance from
relevant antitrust authorities is obtained.
About Eurazeo
o Eurazeo is a leading global investment company, with a diversified portfolio
of EUR17 billion in assets under management, including nearly EUR11 billion
from third parties, invested in over 300 companies. With its considerable
private equity, venture capital, real estate, private debt and fund of funds
expertise, Eurazeo accompanies companies of all sizes, supporting their
development through the commitment of its 235 professionals and by offering
deep sector expertise, a gateway to global markets, and a responsible and
stable foothold for transformational growth. Its solid institutional and family
shareholder base, robust financial structure free of structural debt, and
flexible investment horizon enable Eurazeo to support its companies over the
long term.
Eurazeo has offices in Paris, New York, Sao Paulo, Buenos Aires, Shanghai,
London, Luxembourg, Frankfurt and Madrid.
o Eurazeo is listed on Euronext Paris.
o ISIN: FR0000121121 - Bloomberg: RF FP - Reuters: EURA.PA
EURAZEO CONTACTS
CAROLINE COHEN
Head of Investor Relations
email: ccohen@eurazeo.com
Tel: +33 (0)1 44 15 16 76
VIRGINIE CHRISTNACHT
Head of Communications
email: vchristnacht@eurazeo.com
Tel: +33 1 44 15 76 44
PRESS CONTACT
HAVAS PARIS
AMELIE DE BOURBON PARME
email: amelie.debourbonparme@havas.com
Tel: +33 (0)6 09 01 68 25
For more information, please visit the Group's website: www.eurazeo.com
Follow us on Twitter, Linkedin, and YouTube